aminoglutethimide has been researched along with Nausea in 7 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-five patients with advanced breast cancer, progressive despite prior endocrine therapy in all cases and prior chemotherapy in most cases, were treated with aminoglutethimide, 250 mg four times a day." | 7.66 | Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer. ( Coates, AS; Fox, RM; Kaye, SB; Tattersall, MH; Woods, RL, 1982) |
| "Thirty-eight metastatic breast cancer patients were treated with aminoglutethimide." | 7.66 | Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen. ( Blumenschein, GR; Buzdar, AU; Legha, SS; Powell, KC, 1982) |
| "A group of 213 unselected postmenopausal women with advanced breast cancer were treated with aminoglutethimide, 250 mg 4 times a day, and hydrocortisone, 20 mg 2 times a day." | 7.66 | Aminoglutethimide in the treatment of advanced postmenopausal breast cancer. ( Harris, AL; Powles, TJ; Smith, IE, 1982) |
| "Seventy-three women with metastatic breast cancer were treated with aminoglutethimide and dexamethasone." | 7.66 | Treatment of metastatic breast cancer with aminoglutethimide. ( Asbury, RF; Bakemeier, RF; Bennett, JM; Fölsch, E; McCune, CS; Savlov, E, 1981) |
| "Sixty-five patients with advanced breast cancer, progressive despite prior endocrine therapy in all cases and prior chemotherapy in most cases, were treated with aminoglutethimide, 250 mg four times a day." | 3.66 | Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer. ( Coates, AS; Fox, RM; Kaye, SB; Tattersall, MH; Woods, RL, 1982) |
| "Thirty-eight metastatic breast cancer patients were treated with aminoglutethimide." | 3.66 | Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen. ( Blumenschein, GR; Buzdar, AU; Legha, SS; Powell, KC, 1982) |
| "A group of 213 unselected postmenopausal women with advanced breast cancer were treated with aminoglutethimide, 250 mg 4 times a day, and hydrocortisone, 20 mg 2 times a day." | 3.66 | Aminoglutethimide in the treatment of advanced postmenopausal breast cancer. ( Harris, AL; Powles, TJ; Smith, IE, 1982) |
| "Seventy-three women with metastatic breast cancer were treated with aminoglutethimide and dexamethasone." | 3.66 | Treatment of metastatic breast cancer with aminoglutethimide. ( Asbury, RF; Bakemeier, RF; Bennett, JM; Fölsch, E; McCune, CS; Savlov, E, 1981) |
| "Aminoglutethimide (Elipten), at a dosage between 250 and 1500 mg/d by mouth, was administered in a clinical phase II study to 17 patients with metastasizing carcinoma of the breast resistant to hormones and cytostatic drugs." | 2.65 | [Aminoglutethimide in metastasizing carcinoma of the breast resistant to hormonal and cytostatic treatment (author's transl)]. ( Rieche, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaye, SB | 1 |
| Woods, RL | 1 |
| Fox, RM | 1 |
| Coates, AS | 1 |
| Tattersall, MH | 1 |
| Buzdar, AU | 1 |
| Powell, KC | 1 |
| Legha, SS | 1 |
| Blumenschein, GR | 1 |
| Lipton, A | 1 |
| Harvey, HA | 1 |
| Santen, RJ | 1 |
| Boucher, A | 1 |
| White, D | 1 |
| Bernath, A | 1 |
| Dixon, R | 1 |
| Richards, G | 1 |
| Shafik, A | 1 |
| Ingle, JN | 1 |
| Green, SJ | 1 |
| Ahmann, DL | 1 |
| Edmonson, JH | 1 |
| Nichols, WC | 1 |
| Frytak, S | 1 |
| Rubin, J | 1 |
| Harris, AL | 1 |
| Powles, TJ | 1 |
| Smith, IE | 1 |
| Asbury, RF | 1 |
| Bakemeier, RF | 1 |
| Fölsch, E | 1 |
| McCune, CS | 1 |
| Savlov, E | 1 |
| Bennett, JM | 1 |
| Rieche, K | 1 |
3 trials available for aminoglutethimide and Nausea
| Article | Year |
|---|---|
Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Topics: Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Castration; Clinical Trials as Topic; Drug Admi | 1982 |
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combinatio | 1982 |
[Aminoglutethimide in metastasizing carcinoma of the breast resistant to hormonal and cytostatic treatment (author's transl)].
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Nause | 1981 |
4 other studies available for aminoglutethimide and Nausea
| Article | Year |
|---|---|
Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Nause | 1982 |
Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Dizziness; Edema; Female; Fever; Humans; Middle Ag | 1982 |
Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
Topics: Age Factors; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Therapy, Com | 1982 |
Treatment of metastatic breast cancer with aminoglutethimide.
Topics: Aminoglutethimide; Breast Neoplasms; Dexamethasone; Female; Hormones; Humans; Middle Aged; Nausea; N | 1981 |